• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Rates of high-risk prescribing significantly underreported by Medicare plans

bys25qthea
September 30, 2013
in Chronic Disease, Public Health
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

Image: PD

1. High-risk prescribing was significantly underreported when Medicare Advantage plan-reported rates were compared with rates calculated from Medicare data. 

2. Plans with greater reporting disparities were ranked higher in performance compared to plans with fewer disparities. 

3. Errors arise from improper exclusion of patients from analyses as well as improper categorization of analyzed patients. 

Evidence Rating Level: 3 (Average)

Study Rundown: The recent emphasis on quality assessments have led to increased awareness of public reporting of clinical performance.  These data are important for the determination of reimbursement rates as well as helping patients select plans, hospitals, and providers.  This study investigated the accuracy of Medicare Advantage plan reported performance in minimizing high-risk prescribing amongst elderly patients.  Reported rates of patients over 65 who were prescribed at least one medication listed on the Drugs to Avoid in the Elderly form were compared with rates compiled from Medicare data from 2006 to 2007.  The results demonstrated that plan-reported rates of high-risk prescribing were significantly lower than actual rates from audited data.  This study also found that plans with greater reporting disparities were ranked higher in performance compared to plans with fewer disparities.  These results are consistent with prior studies showing inaccuracies in reporting of various other quality measures.  The major limitation of this study is that the plans included in the analysis were those that participated in various reporting schemes, thus limiting generalizability of these findings towards other plans; generalizability is further decreased due to the single outcome measure assessed.

Click to read the study, published today in the Annals of Internal Medicine

RELATED REPORTS

Primary care physicians underuse Medicare prevention and coordination codes

Accelerated approval drugs incur significant fee-for-service Medicare costs

United States providers increased prescribing of buprenorphine/naloxone

Relevant Reading: Accuracy of Electronically Reported “Meaningful Use” Clinical Quality Measures: A Cross-sectional Study

In-Depth [cross-sectional comparison]: This study obtained data from Healthcare Effectiveness Data and Information Set (HEDIS), Medicare Health Outcomes Survey (HOS), and Medicare Part D event file records, which were compared to plan-reported data.  Data from plans were excluded if they were not complete (i.e. the plan only participated in HEDIS reporting or only Part D reporting).  The primary outcome was rate of high-risk prescribing (prescription of at least one medication with the HEDIS Drugs to Avoid in the Elderly indicator to patients over 65).  Differences between reported and calculated rates were compared at the plan level as well as the individual level using ANOVA and t-tests.

172 Medicare plans were included in this analysis.  While the mean reported rate of high-risk prescribing was 21.1% (95% CI 20.0%-22.3%), the mean calculated rate was 26.9% (95% CI 25.9%-28.0%).  The mean difference between reported and calculated rates was -5.8% (95% CI -6.4 to -5.2%).  95% of plans reported rates that were lower than those calculated.  When the 172 plans were ranked by rate of high-risk reporting, the 18 plans with the highest discrepancies (>10%) were ranked on average 49.1 positions higher based on their reported rate rather than the calculated rate.  Individual-level analysis of 103,680 patients found that plans incorrectly excluded 10.3% of these patients from their reports.  Of those that were included in HEDIS reports, 8% of the patients were incorrectly categorized between high-risk and non-high-risk.

By Steven Zhao and Aimee Li MD

More from this author: Varenicline safe for smoking cessation in patients with stable major depressive disorder

© 2013 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.  

Tags: medicare
Previous Post

Psychotropic medication use declining in children with behavioral disorders

Next Post

Busy ICUs have shorter patient stays and more readmissions; short term outcomes unaffected

RelatedReports

Parental debt influences child socioemotional well-being
Chronic Disease

Primary care physicians underuse Medicare prevention and coordination codes

July 11, 2022
Estrogen withdrawal associated with perimenopausal depression
Oncology

Accelerated approval drugs incur significant fee-for-service Medicare costs

June 22, 2022
Patients with low back pain or pain at multiple sites at highest risk for chronic opioid use
Wellness

United States providers increased prescribing of buprenorphine/naloxone

September 28, 2021
Psychological impact of COVID-19 on health care workers in Singapore
Psychiatry

Association of ECT with risks of all-cause mortality and suicide in older Medicare patients

September 15, 2021
Next Post
Hypercortisolemia in ICU patients is due to reduced cortisol metabolism, not increased production

Busy ICUs have shorter patient stays and more readmissions; short term outcomes unaffected

The UPLIFT trial: Tiotropium in chronic obstructive pulmonary disease [Classics Series]

Surgical learning curve: factors in minimally invasive mitral valve surgery

Bariatric surgery not associated with hypothesized reduction in opioid use

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Bisphosphonates, denosumab, abaloparatide, teriparatide, and romosozumab reduce postmenopausal fracture risk
  • Epstein-Barr viral load monitoring reduces risk of post-liver transplant lymphoproliferative disease
  • Homicide deaths are on the rise for children living in the United States
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options